普罗布科尔通过上调血红氧酶-1的调节来保护平滑肌肉细胞的增殖
Yi-Mo Deng1, Ben J Wu, Paul K Witting
1Centre for Vascular Research, University of New South Wales, and the Department of Haematology, Prince of Wales Hospital, Sydney. Australia.
Circulation
|September 15, 2004
概括
普罗布科尔是一种口服药物,诱导血红素氧酶-1 (HO-1),抑制血管光滑肌肉细胞的增殖. 这种机制解释了普鲁科尔如何预防复,并准闭塞性血管疾病.
科学领域:
- 血管生物学 血管生物学
- 药理学 药理学是指药理学的学科.
- 分子医学是分子医学.
背景情况:
- 已知血液氧化酶-1 (HO-1) 诱导抑制了血管光滑肌肉细胞的增殖和内脏变厚.
- 普罗布科尔是一种口服药物,可以抑制缩,但其作用机制尚未完全理解.
研究的目的:
- 研究probucol抑制血管光滑肌肉细胞增殖和复原的机制.
- 确定普鲁科尔是否诱导血氧酶-1 (HO-1),以及这种诱导是否有助于其治疗作用.
主要方法:
- 新西兰白被食了果强化的,并分析了HO-1 mRNA和活动的动脉.
- 子大动脉光滑肌细胞 (RASMCs) 用probucol治疗,并评估HO-1诱导和细胞增殖.
- 使用HO抑制剂和小干扰RNA (siRNA) 来对HO-1进行敲击,证实了HO-1的作用.
主要成果:
- 普罗布可尔显著增加了子主动脉和培养RASMC中的HO-1mRNA和HO活性.
- 在受伤的大动脉中,Probucol治疗增强了中间细胞的亡.
- 普鲁科尔的HO-1诱导与RASMC增殖的抑制有关,这种效应取决于HO-1活性.
结论:
- 普罗布科尔在血管组织中诱导血红氧酶-1 (HO-1).
- 普鲁科尔的HO-1诱导有助于抑制血管光滑肌肉细胞增殖.
- 这一发现阐明了普罗布科尔对抗静止病的机制,并确定HO-1为闭塞性血管疾病的治疗点.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K


